logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Aldosterone Antagonist class drugs

    FiltersReset Filters
    9 results

    • aldactone

      (spironolactone)
      Pfizer Laboratories Div Pfizer Inc
      Usage: ALDACTONE is indicated for treating NYHA Class III-IV heart failure, hypertension, edema from hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism. It helps increase survival, manage edema, lower blood pressure, and provide preoperative or maintenance therapy for hyperaldosteronism cases.

    • carospir

      (CaroSpir)
      CMP Pharma, Inc.
      Usage: CAROSPIR is indicated for treating NYHA Class III-IV heart failure and reduced ejection fraction in adults to improve survival and reduce hospitalization. It also serves as an add-on therapy for hypertension management and is used for managing edema in cirrhotic patients unresponsive to fluid or sodium restriction.

    • inspra

      (eplerenone)
      Viatris Specialty LLC
      Usage: INSPRA is indicated for improving survival in stable patients with symptomatic heart failure and reduced ejection fraction post-myocardial infarction, as well as for treating hypertension to lower blood pressure and reduce cardiovascular event risks, including strokes and myocardial infarctions. It can be used alone or with other antihypertensives.

    • spironolactone

      (SPIRONOLACTONE)
      Sun Pharmaceutical Industries, Inc.
      Usage: Spironolactone tablets are indicated for treating NYHA Class III-IV heart failure, hypertension as add-on therapy, managing edema due to hepatic cirrhosis or nephrotic syndrome, and for primary hyperaldosteronism in both preoperative and long-term maintenance settings.

    • spironolactone

      (spironolactone)
      Zydus Pharmaceuticals (USA) Inc.
      Usage: Spironolactone is indicated for treating NYHA Class III-IV heart failure with reduced ejection fraction, hypertension (as add-on therapy), edema due to hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism (both preoperative and long-term therapy). It helps manage survival, edema, and blood pressure effectively.

    • spironolactone

      (spironolactone)
      Zydus Lifesciences Limited
      Usage: Spironolactone is indicated for NYHA Class III-IV heart failure, hypertension as add-on therapy, edema from hepatic cirrhosis or nephrotic syndrome, and management of primary hyperaldosteronism. It enhances survival, reduces hospitalization, manages blood pressure, and addresses edema by increasing serum potassium in specific conditions.

    • spironolactone

      (Spironolactone)
      Amneal Pharmaceuticals of New York LLC
      Usage: Spironolactone is indicated for treating NYHA Class III-IV heart failure, hypertension, edema due to hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism. It enhances survival, manages edema, lowers blood pressure, and is used in conjunction with other therapies where necessary.

    • spironolactone

      (spironolactone)
      Accord Healthcare, Inc.
      Usage: Spironolactone is indicated for treating NYHA Class III-IV heart failure, hypertension (as adjunct therapy), edema from hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism (both preoperative and long-term maintenance). It helps improve survival, manage edema, and lower blood pressure, reducing cardiovascular risk.

    • spironolactone and hydrochlorothiazide

      (Spironolactone and Hydrochlorothiazide)
      Sun Pharmaceutical Industries, Inc.
      Usage: Spironolactone and hydrochlorothiazide tablets are indicated for managing edema in congestive heart failure, cirrhosis with edema, nephrotic syndrome, and essential hypertension. They can also treat diuretic-induced hypokalemia and are used cautiously in pregnancy when edema is pathologic. Unnecessary use should be avoided.